Related references
Note: Only part of the references are listed.SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19
Hitoshi Kawasuji et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Predictors ofCOVID-19 severity: A literature review
Benjamin Gallo Marin et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19
Shoji Miki et al.
PLOS ONE (2021)
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
Weilie Chen et al.
EMERGING MICROBES & INFECTIONS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Predicting Disease Severity and Outcome in COVID-19 Patients
Youley Tjendra et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
ICU re-organisation to face the first COVID-19 epidemic wave in a tertiary hospital
Olivier Collange et al.
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2020)
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
Aurelie Velay et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation
M. Solis et al.
JOURNAL OF INFECTION (2019)
Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients
Robert Strassl et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults
Mats Haloschan et al.
AGE (2014)